Skip to main content
uniQure N.V. logo

uniQure N.V. — Investor Relations & Filings

Ticker · QURE ISIN · NL0010696654 LEI · 724500RPCTZLFYJZ3S98 US Manufacturing
Open in API
Filings indexed 859 across all filing types
Latest filing 2017-05-01 Proxy Solicitation & In…
Country NL Netherlands
Listing US QURE

About uniQure N.V.

https://www.uniqure.com/

uniQure N.V. is a gene therapy company focused on developing and commercializing treatments for patients with rare and severe diseases. The company utilizes its adeno-associated virus (AAV) based technology platform to create single-administration therapies with the potential for curative results. Its research and development pipeline is concentrated on liver-directed and central nervous system (CNS) disorders, with a key clinical program targeting Huntington's disease. uniQure aims to deliver transformative medicines by translating scientific innovation into viable treatments.

Recent filings

Filing Released Lang Actions
DEF 14A
Proxy Solicitation & Information Statement
2017-05-01 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the termination of a material definitive agreement related to the commercialization of Glybera, including details about the termination agreement and related financial obligations. It also references a press release attached as an exhibit. There are no financial statements or detailed financial data presented, nor is this an earnings release or annual/interim report. The document is an announcement of a significant corporate event (termination of a material agreement) rather than a financial report or management discussion. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2017-04-20 English
PRE 14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, specifically a Preliminary Proxy Statement for the 2017 Annual General Meeting of Shareholders of uniQure N.V. It includes detailed information about the meeting agenda, voting proposals, board appointments, and instructions for shareholders to vote. It also references the Annual Report on Form 10-K as accompanying material but does not contain the full annual report itself. The document is not a full Annual Report (10-K) but rather the proxy solicitation materials sent to shareholders to inform and request votes for the AGM. Therefore, it fits the definition of Proxy Solicitation & Information Statement (PSI). The document length (15,000 characters) and content confirm it is the proxy statement itself, not just an announcement or a brief notice.
2017-04-18 English
Regulatory Filings 2017
Regulatory Filings
2017-03-31 English
Regulatory Filings 2017
Regulatory Filings
2017-03-29 English
AW
Regulatory Filings Classification · 100% confidence The document is a letter addressed to the Securities and Exchange Commission (SEC) requesting the withdrawal of Amendment No. 1 to a Registration Statement on Form F-3. It references regulatory rules (Rule 477 of Regulation C under the Securities Act of 1933) and discusses procedural matters related to the filing and withdrawal of a registration statement amendment. The document is short (1762 characters) and is a formal regulatory communication rather than a financial report or detailed filing. It does not contain financial data, audit information, or management discussion. It is a regulatory filing related to the withdrawal of a registration statement amendment, which fits best under the category of Regulatory Filings (RNS).
2017-03-28 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.